Cargando…
Pharmacogenomic Testing: Clinical Evidence and Implementation Challenges
Pharmacogenomics can enhance patient care by enabling treatments tailored to genetic make-up and lowering risk of serious adverse events. As of June 2019, there are 132 pharmacogenomic dosing guidelines for 99 drugs and pharmacogenomic information is included in 309 medication labels. Recently, the...
Autores principales: | Hippman, Catriona, Nislow, Corey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789586/ https://www.ncbi.nlm.nih.gov/pubmed/31394823 http://dx.doi.org/10.3390/jpm9030040 |
Ejemplares similares
-
Pharmacogenomic testing in paediatrics: Clinical implementation strategies
por: Barker, Charlotte I. S., et al.
Publicado: (2022) -
Scientific Challenges and Implementation Barriers to Translation of Pharmacogenomics in Clinical Practice
por: Lam, Y. W. Francis
Publicado: (2013) -
Opportunities and challenges of implementing Pharmacogenomics in cancer drug development
por: Tarantino, Paolo, et al.
Publicado: (2019) -
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives
por: Patel, Jai N
Publicado: (2016) -
Pharmacogenomics at the Point of Care: A Community Pharmacy Project in British Columbia
por: Breaux, Samantha, et al.
Publicado: (2020)